The “Elpis” Registry on Percutaneous Coronary Interventions: A Three-Year Experience

Authors

  • George Michas Department of Cardiology, “Elpis” General Hospital of Athens, Athens, Greece
  • Pavlos Stougiannos Department of Cardiology, “Elpis” General Hospital of Athens, Athens, Greece
  • Gerasimos Gabrielatos Department of Cardiology, “Elpis” General Hospital of Athens, Athens, Greece
  • Ioannis Kaplanis Department of Cardiology, “Elpis” General Hospital of Athens, Athens, Greece
  • Thomas Thomopoulos Department of Cardiology, “Elpis” General Hospital of Athens, Athens, Greece
  • Konstantinos Grigoriou Department of Cardiology, “Elpis” General Hospital of Athens, Athens, Greece
  • Eleftheria Malaksianaki Department of Cardiology, “Elpis” General Hospital of Athens, Athens, Greece
  • Athanasios Trikas Department of Cardiology, “Elpis” General Hospital of Athens, Athens, Greece

Keywords:

registry, coronary artery disease, myocardial infarction, percutaneous coronary intervention

Abstract

The advent of percutaneous coronary intervention (PCI) transformed the treatment of obstructive coronary artery disease (CAD) by creating a less invasive revascularization option to coronary-artery bypass grafting (CABG).1 Although, randomized controlled clinical trials (RCTs) are the gold standard in medical research, there is not always the possibility to conduct properly designed RCTs. The gap between evidence from RCTs and clinical practice can be filled by epidemiological studies and properly designed registries.2 The results of the Hellenic Heart Registry on Percutaneous Coronary Interventions (HHR-PCI), a national registry of patients with stable angina or acute coronary syndromes who underwent PCI, were only recently published.3 The purpose of the current study is to report the experience of a newly formed Catheterization laboratory at a tertiary hospital of Athens and to compare its findings to those reported by the HHR-PCI... (excerpt)

Downloads

Published

2017-08-01

Issue

Section

Research Letter